Actelion, Sanofi eye Intermune

Intermune (ITMN) is the latest pharmaceutical company to be linked with merger news, with the Betaville blog reporting that the firm is the subject of takeover interest from Actelion (ALIOF) and Sanofi (SNY).

Actelion has apparently lined up $3-4B in financing from several banks, including JPMorgan.

Intermune shares are +1.8% premarket; its market cap is $3.02B as of yesterday's close.

From other sites
Comments (1)
  • asegpi
    , contributor
    Comments (27) | Send Message
    old story recycling b4 news...interesting
    29 Apr 2014, 08:21 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs